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Abstract 
Elevated-temperature polyol-based colloidal-chemistry approach allows for the development of 
size-tunable (50 and 86 nm) assemblies of maghemite iso-oriented nanocrystals, with enhanced 
magnetization. 
1
H-Nuclear Magnetic Resonance (NMR) relaxometric experiments show that the 
ferrimagnetic cluster-like colloidal entities exhibit a remarkable enhancement (4 ÷ 5 times) in the 
transverse relaxivity, if compared to that of the superparamagnetic contrast agent Endorem

, over 
an extended frequency range (1-60 MHz). The marked increase of the transverse relaxivity r2 at a 
clinical magnetic field strength (~1.41 T), which is 405.1 and 508.3 mM
-1
 s
-1
 for small and large 
assemblies respectively, allows to relate the observed response to the raised intra-aggregate 
magnetic material volume fraction. Furthermore, cell tests with murine fibroblast culture medium 
confirmed the cell viability in presence of the clusters. We discuss the NMR dispersion profiles on 
the basis of relaxivity models to highlight the magneto-structural characteristics of the materials for 
improved T2-weighted magnetic resonance images. 
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A Introduction 
Over the past decade, there has been a considerable progress in the synthesis of colloidal inorganic 
nanocrystals and in their exploitation for applications in various fields, straddling from electronics 
and optoelectronics
1
 to nanomedicine and clinical practice
2
. An interesting development in this 
direction involves the synthesis of colloidal nanocrystals made of multiple subunits arranged in a 
controlled topological fashion
3, 4
 or self-assembled in cluster-like structures (e.g. of -Fe2O3, Fe3O4, 
PbS, ZnO, TiO2 etc)
5-9
. Their synthesis is either the result of direct specific interactions (e.g. van der 
Waals attractions, steric repulsions, attractive depletion or capillary forces, Coulomb forces etc.) of 
their discrete components, or of some external stimulus, such as light, magnetic or electric fields.
10
 
The coexistence within the same nanoscale entity of distinct material sections, directly 
interconnected through inorganic interfaces, or secondary structures communicating through strong 
interactions, enables multifunctionality. This is because coupling between mechanisms is 
established across the interfaced material domains,
11,12,13
 while the physical properties may also 
have a collective nature.
14
 Based on these appealing features, such multifunctional systems are 
promising for technological areas entailing biology and biomedicine. Furthermore, those materials 
featuring a soft magnetic state in conjunction with some other non-homologous property (e.g. 
plasmonic or excitonic emission) and with appropriate surface biocompatible coatings, occupy a 
prominent position in this scenario: 
4, 9
 they can be exploited for in-vivo biomedical applications, 
such as magnetically driven contrast enhancement,
15, 16
 selective hyperthermia treatment
17
, and even 
targeted drug delivery
18
. 
 Specifically, the afore-mentioned iron-oxides based nanomaterials emerge as promising probes in 
bionanotechnology as they allow for a novel approach to the diagnosis of various diseases with 
magnetic resonance imaging (MRI). During the last two decades, several commercial MRI contrast 
agents have been developed for clinical studies. The majority of such systems are based on 
superparamagnetic iron-oxide nanoparticles, coated with hydrophilic polymers or sugars, including 
Endorem

, Resovist

, and Combidex

. However, poly-dispersity and poor crystallinity are often 
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the most common limitations of such systems, originating from the synthesis protocol; as a result,  
magnetic properties and contrast efficiencies vary from one batch to another. 
19, 20 
 To develop new magnetic compounds for improved MR-based diagnostics, it is desirable to 
adjust the magnitude of the particle’s net magnetic moment μ (because R2 = 1/T2  μ
2
, where R2 is 
the transverse relaxation rate and T2 is the spin-spin relaxation time) by controlling the structural 
characteristics of the nano-object, i.e. the nanoparticle’s size, shape, composition and crystallinity.21 
Rapid advances in the chemical routes for the synthesis of size and shape controlled, surface 
functionalised magnetic nanoparticles,
22, 23
 lead to increased particle magnetizations and enhanced 
image contrast, preserving biocompatibility at the same time. As individual Superparamagnetic Iron 
Oxide Nanocrystals (SPIONs) tend to give relatively low magnetization,
21
 to improve the MRI 
contrast, larger colloidal entities composed of primary nanocrystals (PNCs), which are self-
assembled
24
 or incorporated into polymer matrices, have been investigated. The latter approach, for 
instance, entails SPIONs encapsulated in polyacrylamine
25
, silica
26
, phospholipid micelles
27
, block 
polymers
28
 or amphiphilic polymers
29, 30
, while the former assembling approaches lead to efficient 
“clustering” of individual PNCs, and  promote close contact. In turn, this pathway further boosts the 
magnetization of such nanostructures, while the proximity of nanoparticles within the cluster 
promotes the coupling of the neighboring magnetic moments and results in a stronger perturbation 
of the local magnetic field in their vicinity. Indeed, the hydrogen nuclear moments relax faster, 
leading to a strong contrast in the MRI images. Magnetic nanoclusters of this type have been 
developed with capping agents of different nature, including oleylamine/oleic acid,
31, 32
 citrate,
33-35
 
polymers
7, 9, 24, 36-44
 or block copolymers
45-47
. When the enlarged cluster-like entity contains a 
biocompatible polymer-coating such as polyvinyl alcohol (PVA), poly(ethylene glycol)- co 
fumarate (PEGF) or cross linked PEGF, wide-spread opportunities in biomedical field become 
possible.
24
 These colloidal nanoclusters agents feature an improved contrast efficiency with respect 
to commercial compounds, or at least their MRI contrast response is comparable to that of the 
widely available compound Endorem

.  
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 In the present work we report on size-controlled assemblies of pure maghemite (γ-Fe2O3) 
PNCs, which are crystallographically aligned within the hydrophilic colloidal nanoclusters (CNCs). 
Our system displays a weak ferrimagnetic behavior, in contrast to the majority of the known 
nanoparticle-based aggregates devised for MR-based applications. We suggest that careful 
engineering of the CNCs’ magneto-structural characteristics produces a remarkable improvement of 
r2 (about four-to-five times higher) compared to Endorem

. From the point of view of design 
criteria we suggest that an increased intra-aggregate magnetic material volume fraction and the 
proper choice of the surfactant, allowing the water proton penetration, is a necessary condition for 
the superior MR-related contrast enhancing features of such low-cytotoxicity nanoarchitectures. 
 
B Experimental 
B.1 Materials.  
All reagents were used as received without further purification. Anhydrous iron chloride (FeCl3, 
98%), was purchased from Alfa Aesar (United States). Anhydrous Sodium hydroxide (NaOH, 
98%), polyacrylic acid (PAA, Mw= 1800), were purchased from Sigma Aldrich (United States), 
while Diethylene glycol (DEG, (HOCH2CH2)2O) of Reagent (<0.3%) and Laboratory (<0.5%) 
grades were purchased from Fisher (United States). The absolute Ethanol was purchased from 
Sigma Aldrich.  
Cell cultures.  
NIH/3T3 murine fibroblasts (ATCC- American Type Culture Collection) were suspended at a 
concentration of 10
5
 cells/mL in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS) and 1% antibiotic solution (GIBCO, Invitrogen, Karlsruhe, 
Germany); cells were then cultured at 37 °C, in an atmosphere of 5% CO2, and detached when 
growth reached 75% confluence using 0.05% trypsin/EDTA (GIBCO, Invitrogen, Karlsruhe, 
Germany).  
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B.2 Synthesis of γ-Fe2O3 Nanoparticle Clusters.  
The CNCs were synthesized by a modified high-temperature colloidal chemistry protocol based on 
a one-step polyol process first reported by Yin and co-workers.
48
 All syntheses were carried out 
under argon atmosphere in 100-mL round-bottom three-neck flasks connected via a reflux 
condenser to standard Schlenk line setup, equipped with immersion temperature probes and 
digitally-controlled heating mantles. The reactants, FeCl3, NaOH, polyacrylic acid (PAA, Mw= 
1800), diethylene glycol (DEG), except Ethanol, were stored and handled under anaerobic 
conditions in an Ar-filled glove-box (MBRAUN, UNILab). Crucially, utilising two types of DEG 
grades allowed for assemblies of iron-oxide nanocrystals with small and large diameter to be 
prepared upon increasing water content in the reaction mixture. Observation of the purified 
nanocluster samples by transmission electron microscopy, at regular time-intervals over a period of 
a year, have shown that they are stable with no aggregation among their units. Details of the 
synthetic protocol can be found elsewhere.
49
  
 
B.3 Characterization techniques. 
a) Transmission electron microscopy (TEM).  
Low-magnification and high-resolution TEM images were recorded on a LaB6 JEOL 2100 electron 
microscope operating at an accelerating voltage of 200 kV. For the purposes of the TEM analysis, a 
drop of a diluted colloidal nanoparticle aqueous solution was deposited onto a carbon-coated copper 
TEM grid. All the images were recorded by the Gatan ORIUS
TM
 SC 1000 CCD camera and the 
structural features of the nanostructures were studied by two-dimensional (2D) fast Fourier 
transform (FFT) analysis.  
b) Magnetic Measurements.  
The magnetic properties of the samples were studied by means of a Superconducting Quantum 
Interference Device (SQUID) magnetometer (Quantum Design MPMS XL5). The magnetic 
measurements were performed with the dried powder of the nanomaterials. The magnetic data have 
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been normalized to the mass of the γ-Fe2O3, as derived by Inductively Coupled Plasma Atomic 
Emission Spectroscopy (ICP-AES) analysis ([Fe]50.2 nm CNCs = 44.9 ± 0.3 mM, [Fe]85.6 nm CNCs = 42.3 
± 0.3 mM).  
c) Nuclear Magnetic Resonance (NMR).  
Two solutions of CNCs were prepared for the NMR investigation, having an iron concentration C= 
1.225 and 1.208 mmol/L, as determined by ICP-AES measurements for small and large CNCs, 
respectively. NMR longitudinal and transverse relaxation times were measured by using two 
different pulsed Fourier Transform (FT)-NMR spectrometers: i) a Smartracer Stelar relaxometer 
(using Fast-Field-Cycling, FFC, technique) for frequencies in the range 0.01  10 MHz, and ii) a 
Stelar Spinmaster relaxometer for  10 MHz. We used a common saturation recovery sequence to 
measure the longitudinal (spin-lattice, T1) nuclear relaxation time. Standard radio frequency 
excitation pulse sequences, CPMG for  > 3 MHz and pre-polarized Hahn echo sequence for  < 3 
MHz, were used to measure the  transverse (spin-spin, T2) nuclear relaxation time. The investigated 
frequency range 0.01  60 MHz corresponds to an external magnetic field H= 0.00023 - 1.41 
Tesla (ω= γ Η, where ω is the Larmor frequency and γ/2π= 42.58 MHz/T). The magnetic field range 
was chosen in order to cover the typical fields used in both clinical and research laboratory MRI 
tomography (H= 0.2, 0.5 and 1.5 Tesla). The measurements at room and physiological temperatures 
gave the same results within 10 %. 
The efficiency of the CNCs as MRI contrast agents was determined by calculating the nuclear 
longitudinal and transverse relaxivities, r1 and r2 respectively, defined as 
C
diam)i(1/Tmeas)i(1/T
i
r

 , i = 1, 2 (1) 
where (1/Ti)meas is the value measured for the solutions with concentration C (mmol/L) of the 
magnetic center and (1/Ti)diam represents the nuclear relaxation rate of the diamagnetic host solution, 
which in our case is water.
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d) Cell Viability Assay.  
The interaction of the cells with the CNCs was evaluated using the live-dead cell staining kit 
(Biovision). The assay protocol has been described in previous studies.
50, 51
 Cell suspension (10
5 
cells/mL) was deposited in 24-well plates and cultivated for 1, 3, 5 and 7 days. In parallel, different 
concentration of CNCs (25, 50, 100 and 200 μg/mL Fe) was added in the cell suspension for every 
different culture period. Cells that remained alive after certain days of cultivation were stained 
green whilst dead cells were stained yellow-red. The images were recorded in a Zeiss fluorescence 
microscope equipped with a Laser scanning system Radiance 2100 (400-700 nm) and a Carl-Zeiss 
Axio Camera HR. Experiments were repeated at least three times for each size and available 
concentration of the CNCs. 
e) Cell Proliferation Assay.  
Quantification of live cells after each day of culture was performed by using ATP-Glo 
TM
 
bioluminometric cell viability assay kit (Biotium, Inc.). This highly sensitive homogenous assay for 
quantifying Adenosine Triphosphate (ATP) involves an addition of ATP-Glo
TM 
detection cocktail 
to cells cultured in a serum-supplemented medium. Since ATP is an indicator of metabolically 
active cells, the number of viable cells can be assessed based on the amount of ATP available. This 
ATP detection kit takes advantage of Firefly luciferase’s use of ATP to oxidize D-Luciferin and the 
resulting production of light in order to assess the amount of ATP available. Luminescence 
measurements were performed using the Synergy™ HT Multi-Mode Microplate Reader (BioTek). 
The different CNCs concentrations were tested in duplicates in each individual cell culture 
experiment and these experiments were repeated at least three times. For statistical analysis, the 
data were subjected to one way ANOVA followed by Tukey tests for multiple comparisons between 
pairs of means, using commercially available software (SPSS 21, IBM). 
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C Results and Discussion 
C.1 Morphology and Crystal Structure 
Iron-oxide colloidal assemblies with two different sizes were prepared on the basis of a high-
temperature wet chemistry polyol pathway. The influence of different synthetic parameters
49
 on the 
structural characteristics of the CNCs were carefully examined in order to attain a significant degree 
of size/shape homogeneity. 
57Fe Mössbauer spectra (MS) recorded for the two nanocrystal 
assemblies at 10, 77 and 300 K show similar features, confirming the maghemite (γ-Fe2O3) nature
49
 
of these iron-oxides. Furthermore, bright-field TEM images for two representative samples are 
shown in Figures 1a, d. Both CNCs samples have a flower-like, almost spherical shape without 
aggregation between units. Each nanocluster is an assembly of small PNCs, with no isolated 
nanoparticles left out of the aggregate. The average diameters of the entities are 50.2 ±5.4 and 85.6 
±13.3 nm (Figure 1a, c). Further evidence for the topological arrangement and the crystallographic 
orientation of the assembled nanocrystals is provided by HRTEM images and the calculated FFT 
patterns taken from individual CNCs (Figure 1b, d). The observed diffraction spots suggest that the 
individual nanocrystals are iso-oriented. Analysis of the FFT patterns allowed us to identify that the 
crystal symmetry of the CNCs as a whole is similar to that of the individual, small PNCs, which 
crystallize in the cubic spinel structure. The attractive magnetic dipolar interactions (vide infra) of 
the PNCs are strong enough to counter-balance the electrostatic repulsions and allow for the 
controlled assembly of the PNCs in a secondary structure. During the growth, the as-formed PNCs 
re-orient in the colloid and minimize their surface energy by aggregating through oriented 
attachment, and form a single-crystalline-like secondary nanostructure.
38
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Fig. 1 Low- (a, c) and high- (b, d) resolution TEM images of colloidal nanoclusters (CNCs) of maghemite. Insets to 
panels a, c show the size distribution for CNCs with diameter of 50 and 86 nm. Insets to panels b, d show the calculated 
FFT patterns from an isolated cluster-like structure; the reflections are indexed on the basis of a cubic spinel (fcc) iron-
oxide crystal structure. The corresponding zone-axis is marked by B. 
 
C.2 Magnetic Properties  
In Figures 2a,b the room temperature hysteresis loops indicate that the dried powders of the CNCs 
were ferrimagnetic (FiM) with coercive fields (Hc) of 5.4 and 2.1 Oe, for the small and the large 
CNCs, respectively, while the saturation magnetizations (MS) were of 71.2 and 73.4 emu/g γ-Fe2O3, 
very close to the bulk value of 74 emu/g for γ-Fe2O3.  
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Fig. 2 Magnetic properties of the small (50 nm) and large (86 nm) CNCs: (a) the temperature evolution of the ZFC and 
FC susceptibility, as well as hysteresis loops at 300 K (b) and 5 K (c). 
 
 The hysteretic behavior in the temperature dependent zero-field and field-cooled (ZFC-FC) 
susceptibility (χ) indicates blocked particles below 300 K for both cases (Figure 2a). Since no 
obvious difference between the Mossbauer spectra of the dried powder and those of the frozen 
solutions of the CNCs could be resolved, we conclude that ferrimagnetism of the CNCs can be 
attributed to intra-cluster dipolar interactions only.
49
 
 
C.3 Cytotoxicity 
CNCs appear to satisfy the first prerequisite of tailored magnetic properties for improved MR 
properties. In addition, the purposeful choice of the PAA as surfactant renders the assemblies 
negatively charged (z-potential, was -65.4±10.8 and -50.0±6.5 mV for the small and the large 
CNCs, respectively) with good colloidal stability. However, a second condition for their 
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implementation in the MR-based diagnostics requires verification of their toxicity on living cells. 
For this purpose, murine fibroblast cells (NIH/3T3) were exposed to the CNCs to thoroughly check 
the cell-nanocluster interactions. An ATP-based Glo
TM 
cell viability assay was used for the 
luminometric measurement of the NIH/3T3 cells growth. Since the ATP indicates the metabolically 
active cells, we quantified the number of viable cells based on the concentration of the available 
ATP. ATP concentrations, recorded over a regular period of cultivation time (1, 3, 5 or 7 days), are 
plotted in Figures 3a, b. A series of different concentrations (25, 50, 100 and 200 μg/mL Fe) was 
used for both small and large CNCs. 
 Specifically, the cell growth for different concentrations of the CNCs, for the same number of 
days of culture, displayed no statistical difference when it was compared to the respective control 
samples (cells without CNCs). The significance levels (p) were estimated using one way ANOVA 
followed by Tukey tests (p<0.05). Additionally, the difference in the size of the CNCs did not affect 
the cell proliferation after 1, 3, 5 or 7 days of culture. The unaffected proliferation of NIH/3T3 cells 
under the presence of different concentrations of the CNCs provides valid evidence for the low 
toxicity of the present nanomaterial.  
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Fig. 3 Cytotoxicity profile of the 50 (a) and 86 nm (b) CNCs samples. NIH/3T3 fibroblast cells were incubated with 
CNCs at the indicated doses for 1, 3, 5 and 7 days. ATP-Glo TM Bioluminometric cell viability assay kit was used for 
luminometric measurement of the fibroblasts’ growth. Each histogram reflects the luminescence (mean value in RLU - 
relative luminescence units - ± Standard Deviation-SD) as derived from three independent experiments. Fluorescence 
microscopy images of  live (green) and dead (orange-red) fibroblasts, cultured without CNCs (control) (c, e) and with 
small (d) or large (f) CNCs, after 5 days of culture. 
 
 The viability of fibroblasts was also tested by using a live-dead cell staining kit (BioVision). Cell 
viability was assessed after 1, 3, 5 and 7 days of culture with and without CNCs. Figures 3c-f show 
representative results from a 5-days cell culture and a concentration of 200 μg/mL Fe. The 3 and 7 
days cultures, for all the CNCs concentrations (25-200 μg/mL Fe) show a similar behavior (Figure 
S1). In particular, these images depict the healthy fibroblasts (stained green), while dead cells 
(stained with PI, red) could only rarely be detected even on cell cultures with the highest measured 
concentration (200 μg/mL Fe) and the large CNCs (Figure 3f). In summary, fibroblast cells seem to 
tolerate the CNCs, showing high levels of viability, cell-cell interactions and low levels of toxicity, 
giving further support towards the potential use of the presently developed nanoarchitectures in 
MR-based diagnostics. 
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C.4 The NMR Relaxation Properties and the Influence of the Intra-cluster Magnetic Material 
Volume Fraction.  
Let us now examine how the unique magnetostructural attributes of these nanocrystal assemblies 
can mediate the MR-based properties in view of their perspective imaging capability. The CNCs 
were shown to be ferrimagnetic, thus they are highly magnetized under an applied magnetic field 
and, consequently, they induce a substantial local perturbation of the dipolar magnetic field in their 
vicinity.
21
 However, the possible increase of nuclear relaxation rates, giving a better efficiency in 
contrasting the MRI images, depends also on the dynamic electronic properties of the ensemble. To 
evaluate the physical properties of the system that influence the nuclear relaxation, we performed 
proton NMR relaxometry measurements. The longitudinal r1 and transverse r2 relaxivities (eq. (1)), 
were studied as a function of the measuring frequency for the two CNCs samples and compared 
with those obtained for Endorem
 (Figure 4). Irrespective of the CNCs’ size, the longitudinal r1 
relaxivity (~200 mM
-1
 s
-1
) is higher than that of Endorem

 (10 mM
-1
 s
-1
) at low frequencies (10 kHz 
- 9 MHz), but falls a bit below the commercial product’s values at higher frequencies (10 MHz - 60 
MHz) (Figure 4a). The frequency behavior of r1 is a consequence of the physical mechanisms 
responsible for the nuclear relaxation.
19, 52
 In the low frequency (<1 MHz) range, the very high 
values of r1 () and its flattening reflect the dominant role of the ferrimagnetic CNCs’ high 
magnetic anisotropy. The absence of a maximum in r1(), at   1 MHz, suggests that the diffusion 
process in this frequency range is poorly effective in shortening the nuclear relaxation of water 
protons (see comparison with Endorem, Figure 4a). 
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Fig. 4 Room temperature longitudinal r1 (a) and transverse r2 (b) relaxivities as a function of proton Larmor frequency 
(or the external magnetic field, H) for the 50 (circles) and 86 nm (triangles) CNCs. The corresponding data for the until 
recently commercial contrast agent Endorem® (squares) are also shown. 
 
 On the other hand, the transverse r2 relaxivity, i.e. the crucial relaxivity in T2-relaxing materials, 
is enhanced by a factor 4 (5 for large CNCs) with respect to Endorem (where r2 ~ 100 mM
-1
 s
-1
), 
over almost all the investigated frequency range (Figure 4b). It is worth considering that a recent 
scaling-law approach has shown that the transverse relaxivity depends on three parameters, namely, 
the hydrodynamic diameter, the magnetization of the whole nanoparticle aggregate and the volume 
fraction of the magnetic material.
53
 In that respect the r2 values may be predicted by models 
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assuming that the spin-spin relaxation occurs either in the motional averaging regime (MAR), 
where ΔωτD< 1 or in the static dephasing regime (SDR), where ΔωτD> 5; within the first regime 
the transverse relaxivity increases with the size, while in the second it remains almost unchanged.
54
  
To calculate the expected Larmor frequency shift we first estimated the values of the intra-cluster 
volume fraction, φintra, resorting to the following relation (refer to S2): 
ργ-Fe2O3 ( 1 - fmγ-Fe2O3 ) / (ρPAA fmγ-Fe2O3) =  ( 1 - φintra ) / φintra     (2) 
where ργ-Fe2O3 = 4900 kg/m
3
 is the density of bulk maghemite, ρPAA= 1150 kg/m
3
 is the density of 
the polyacrylic acid, and fmγ-Fe2O3 is the weight fraction of the iron-oxide in a known mass of dried 
nanocluster powders, estimated from the thermogravimetric (TGA) measurements.
2 
Eq. (2) yields 
φintra=0.60 and 0.72 for small and large CNCs, respectively.  
On the other hand, the Larmor frequency shift is expressed as 
Δω = 0 M
*
V / 3         (3) 
where M*V is the normalized magnetization (see Table I), while the translational diffusion time τD  
is defined as D = d
2
 / 4D, where d is the diameter of the CNCs and D = 3 ×10-9 m2/s is the water 
translational diffusion coefficient. τD amounts to ~0.2 and ~0.6 μs, for the small and large CNCs.  
Thus, finally: 
ΔωτD = 4.9     and     ΔωτD = 18.2       (4) 
for small (50 nm) and large (86 nm) CNCs respectively, indicating that the investigated samples fall 
at the extremes of the SDR regime (5 < ΔωτD < 20). We note that, within the SDR regime, the 
straddling water molecules feel a relatively constant dipolar magnetic field in their vicinity and it is 
not surprising that the experimentally observed r2(ν) are marginally dependent on the CNCs’ 
average size. The small difference in the sample volume magnetization, M
*
V, and φintra, is an 
additional reason behind the little variation at   4 MHz (Figure 4b). 
The result of eq. (4) suggests that the transverse relaxivity (r2) values for both CNCs samples may 
be predicted by models assuming that the spin-spin relaxation occurs in the SDR regime.  
17 
 
 
Firstly, if we calculate the expected r2 value with the theoretical (approximate) expression found in 
ref. [53], 
39/2 *
mat02
V
P
theo Mr   
where νmat is a volume fraction to iron concentration conversion factor (νmat = 1.57x10
-5
 m
3
mol
-1
 for 
maghemite), and compare it to the experimental result r2
exp
, we observe a reasonable agreement, 
since r2
theo
/ r2
exp
 = 1.11 and 1.10. Conversely, the expected normalized relaxivity r2
*
 = r2 φintra /M
*
v
2
 
for 50 nm and 86 nm clusters is about 210-8 and 810-8 s-1mM-1m2A-2, respectively, but the real 
values characterizing the two samples are 5.510-9 and 5.410-9 s-1mM-1m2A-2, i.e. an order of 
magnitude different. Such a marked difference evidently hints at a poor agreement between theory 
and experiment; on the other hand, one may argue that samples located at the edges of the SDR 
regime are prone to misbehavior: the 50 nm sample is neither in the motional averaging regime 
(MAR) nor completely in the SDR range, i.e. in a region not described by any existing model; the 
86 nm sample is very close to the ΔωτD ~ 20 limit, where the refocusing pulses used in the T2 
sequence become effective, an effect which is not accounted for by the SDR model. The 
experimental evidence proves, on the other hand, that Endorem

 is not affected by these issues at 
all, since for the commercial compound ΔωτD = 4.4 and r2*= 7.810
-8 
s
-1
mM
-1
m
2
A
-2
, which is 
perfectly in line with the theory. 
 Finally, a justification for the significant (4 to 5 times) increase of r2 with respect to the one of 
Endorem

, can be inferred by considering the almost two-times higher volume magnetization in 
conjunction with the roughly three-times larger intra-cluster volume fraction (Endorem

: M
*
V= 
0.77 105 A/m, φintra= 0.23; Table 1). 
The above discussed points suggest that the φintra parameter has a crucial role in the improvement of 
the MR properties. 
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Table 1. Parameters utilized for the calculation of the intra-cluster magnetic material volume fraction and the 
determination of the transverse relaxivity regime to which CNCs belong. These entail: Dhydro, the hydrodynamic 
diameter of the CNCs; fm γ-Fe2O3, the weight fraction of the iron-oxide in a known mass of dried nanocluster powder as 
derived by the thermogravimetric (TGA) measurements; φintra, the intra-cluster volume fraction of the magnetic 
material; MS, the saturation magnetization of the CNCs at room temperature; M
*
V, the volume magnetization; Δω, the 
Larmor frequency shift; τD, the translational diffusion time. Note: parameter values for Endorem
® tabulated in this table 
were taken from reference [53]. 
Sample Dhydro (nm) fmγ-Fe2O3 (%) φintra M
*
V (10
5
 A/m) ΔωτD Regime 
Endorem
®1
 80 63.8 0.23 0.77 4.4 SDR 
50.2 nm CNCs 78.6 86.8 0.60 1.95 4.9 SDR 
85.6 nm CNCs 121.8 92.1 0.72 2.37 18.2 SDR 
 
C.5 The CNCs Relaxivities and their Relevance for other Ferrite Nanoachitectures 
Two broad categories, depending on the nature of their magnetic state, entailing either 
superparamagnetic (SPM) or ferrimagnetic (FiM) functional structures, are considered. A clear 
enhancement of the transverse relaxivity r2 is presented against individual SPM nanocrystals with 
different capping agents such as, polymers 
19
, dendrons 
55
 or DHAA 
56
. Their size-only dependent 
relaxivity in the MAR regime renders them less efficient T2-relaxation agents compared to the 
CNCs, whose improved faster reduction of T2 is determined by the synergetic action of Ms, size and 
φintra.
53
 However, a progressive increase of the size of individual nanoparticles can lead to FiM 
nanoarchitectures which may provide enhanced relaxivites with the advantages of the SDR regime. 
The only FiM systems of large size and enhanced magnetic anisotropy are the iron-oxide 
nanocubes, with an edge length of 22 nm, encapsulated in PEG-phospholipids, with good colloidal 
stability; these systems have shown a value r2 = 761 mM
-1
s
-1
, higher than our system 
57
 (see Table 
S2 for a more comprehensive comparison).  
 Alternatively, controlled aggregation of nanoparticles in secondary structures can further boost 
19 
 
the relaxivities with an outcome equivalent to the SDR. In this respect, to the best of our 
knowledge, the only ferrimagnetic secondary structure that has been studied so far for its 
outstanding visualizing (T2-weighted contrast properties) as well as drug-delivering actions, is a 
newly designed liposome-encapsulated magnetic nanoparticle cluster. 
58
 This system shows an 
unprecedented r2 of 1286 mM
-1
s
-1
 but at a higher magnetic field of 2.35 T, thus leaving the CNCs a 
valid alternative.  
 Nevertheless, the strategy to embed nanoparticles in matrices/polymers 
44
 
59
 or aggregating them 
in well-controlled morphologies 
32, 33, 36, 40, 45, 46, 60-62
 can also afford SPM nanoarchitectures and 
shows relaxivities explainable within the SDR regime. In this case, our system shows larger r2 (405 
and 510 mM
-1
s
-1
 for the small and large assemblies, respectively) compared to most of the SPM 
cluster-type particles, such as those capped with citrate 
33
, PVP 
36
, polystyrene 
63
, Dextran 
44
, PEG 
39
, (Mal)mPEG-PLA copolymer 
46
, amine 
32
, TREG 
62
. An exception is the SPM magnetite-based 
cluster-analogue of higher r2 relaxivity, which is covered by the same surfactant as ours, but 
synthesized in an autoclave, through a polyol process for an extended period of time (12 hr).
60, 61 
Amongst them, those clusters of diameter 34 and 63 nm (with r2 of 540 and 630 mM
-1
s
-1
, 
correspondingly) have a φintra of 0.30 and 0.50 and MV of 1.23 10
5
 and 1.79 105 A/m, 
respectively, both smaller than the value for CNCs of the present study. The enhanced values of 
their relaxivities suggest that r2 is not mediated only by the latter two magnetostructural parameters, 
but it must also be a function of the surface properties of the assemblies (e.g. thickness of surface 
coating, L, over the hydrodynamic diameter, Dhydro, of the assembly), as the interactions between 
the water protons and the assemblies could occur primarily on their surface.
64
 
65
  
 A further observation is that, in general, r2 can be thought to originate from the variation of the 
diffusion length of the water molecules, relative to the dimensions of the surfactant-coordinated 
inorganic entities themselves. Then, the r2 relaxivity is expected to decrease as the molecular weight 
of the capping agent increases 
64
 , but this appears not to be the case of our system since the clusters 
are capped with a surfactant (PAA) of lower molecular weight (Mw= 1800 versus Mw= 5000
60
). The 
20 
 
possible lower steric hindrance amongst shorter chains,  allows for a higher packing density of a 
larger number of polyacrylate chains to coordinate the nanoclusters’ surface. In turn, this complies 
with the higher z-potential attained by the CNCs in the present case (-65.4 and -50.0 mV for the 
small and the large clusters, compared to -38 and -43 mV, for 34 and 63 nm clusters by Li et al
60
). 
Such a dense surface coverage may impede the penetration ability (diffusivity) of the water 
molecules. As a consequence, the water-proton nuclear moments are less strongly perturbed by the 
local magnetic field generated by the inorganic entities at the surface of the nanoclusters themselves 
and generates a lower r2.  
Other differences may also be attributed to the likely modification of the chemical bonding 
(entailing the surface functionalised nanocrystals of the assembly) in the two cases. This bonding 
can mediate the particles’ magnetic anisotropy or even enhance their surface spin disorder, thus 
having an impact in lowering the relaxivity values 
66, 67
.  
 
Conclusions 
The suggested colloidal chemistry pathway allows to obtain ferrimagnetic assemblies of 
crystallographically oriented primary nanocrystals of maghemite. They are not only well-dispersed 
in aqueous media and have low cytotoxicity, but show an enhanced transverse  NMR relaxivity, r2. 
The results suggest that the pronounced enhancements in the magnitude of r2 have their origin in the 
ability to guide the assembly of individual nanocrystals so that they become crystallographically 
oriented, allowing for an increased magnetic material volume fraction (φintra) within the larger-
grown nanocluster entities. The favourable high intra-cluster volume fraction of the magnetic 
moments appears to make them efficiently coupled to each other in the CNCs. In turn, this permits a 
coherent and intense perturbation of the dipolar magnetic field in the near vicinity of the straddling 
water molecules, a condition that enhances the relaxation of the associated proton nuclear spins. 
The polyacrylate surface coordinating groups of the CNCs further mediate the efficient penetration 
of the water protons and in conjunction with the surface spin disorder of the inorganic nanocrystals 
21 
 
determine the magnitude of r2. Such nanoarchitectures appear to have the potential for improved 
diagnostic quality in the T2-weighted MR imaging techniques. 
Finally, the observations presented in Section 3.4 lead to the conclusion that a definitive theory for 
r2 relaxivity still has to be formulated, and a further effort needs to be sustained to account for 
overlooked effects that may indeed have a strong impact on the relaxometric properties of a 
nanoparticle-based contrast agent. Specifically, we would like to highlight the existence of classes 
of compounds that do not strictly obey the universal scaling law envisioned by Vuong et al
53 
for 
clusters, since when the ΔωτD is at lower and upper limits of the SDR range, predictions based on 
ref. [53] cannot be reliable. 
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S1. Toxicity experiments 
 
 
Figure S1. Fluorescence microscopy images of live (green) and dead (orange-red) fibroblast cells 
cultured without CNCs (a), with 85.6 nm CNCs (I, III), and 50.2 nm CNCs (II, IV) under different 
concentrations (25μg/mL-b, 50 μg/mL-c, 100 μg/mL-d, 200 μg/mL-e), after 3 (I,II) and 7 (III,IV) days 
of culture. The scale bar corresponds to 50 μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 S2. Calculation of the intra-cluster volume fraction of the magnetic material1 
 
Table S1. (Copy of Table 1) Parameters utilized for the calculation of the intra-cluster magnetic 
material volume fraction and the determination of the transverse relaxivity regime where CNCs 
belong. These entail: Dhydro, the hydrodynamic diameter of the CNCs; fm γ-Fe2O3, the weight fraction of 
the iron-oxide in a known mass of dried nanocluster powder as derived by the thermogravimetric 
(TGA) measurements; φintra, the intra-cluster volume fraction of the magnetic material; MS, the 
saturation magnetization of the CNCs at room temperature; MV, the volume magnetization; Δω, the 
Larmor frequency shift; τD, the translational diffusion time. 
 
Sample 
Dhydro 
(nm) 
fm γ-Fe2O3 
(%) 
φintra 
MV 
(105 A/m) 
Δω τD Regime 
Endorem®1 80 63.8 0.23 0.77 4.4 SDR 
50.2 nm CNCs 78.6 86.8 0.60 1.95 4.9 SDR 
85.6 nm CNCs 121.8 92.1 0.72 2.37 18.2 SDR 
 
The transverse relaxivity (r2) regime in which the CNCs belong is determined mainly by three 
quantities, which are material-dependent characteristics, namely: the volume magnetization (MV), the 
volume fraction of the magnetic material (φintra) and the hydrodynamic size (D). 1 
The intra-cluster volume fraction (φintra; Table S1) is calculated by the formula: 
   
intra
intra
OFe γmPAA
OFe γmOFeγ
φ
φ1
fρ
)f(1ρ
32
3232 −
=
−
−
−−
    (1) 
where ρ
 γ-Fe2O3 = 4900 kg/m3, fm γ-Fe2O3 the weight fraction of the iron-oxide in a known mass of dried 
nanocluster powders was estimated from the thermogravimetric (TGA) measurements and ρPAA= 1150 
kg/m3 the density of the polyacrylic acid.2 
The
 
normalized volume magnetization MV*, in A/m, can be calculated by the formula: 
    
32OFeγSintraV Mφ*M −××= ρ      (2) 
where the CNCs’ room temperature saturation magnetizations are MS= 71.2 and 73.4 emu/g for the 
50.2 nm and 85.6 nm CNCs samples, respectively. 
The Larmor frequency shift, Δω is calculated by the formula: 
    
3
*M γμ
Δω V0=
      (3) 
where γ= 2.67513× 108 rad s-1T-1 is the proton gyromagnetic ratio and μ0= 4π×10-7 Τ m Α-1 the 
magnetic permeability of the vacuum. 
The estimated Δω for the 50.2 nm and 85.6 nm CNCs samples are 2.37 ×107 s-1 and 2.95 ×107 s-1, 
respectively. 
The translational diffusion time τD is given by the formula: 
    
D4
D
τ
2
hydro
D =      (4) 
where Dhydro is the hydrodynamic diameter of the CNCs, as calculated from the Dynamic Light 
Scattering (DLS) experiments and D= 3 ×10-9 m2/s the water-proton translational diffusion time . 
The calculated values of the τD are 0.2 and 0.6 μs for the 50.2 nm and 85.6 nm CNCs samples, 
respectively. 
 
Based on the magnitude of the parameters derived from equations (3) and (4), ~5 < Δω τD < ~20 for 
the CNCs (Table S1). For this reason we are of the opinion that the transverse relaxivity (r2) values for 
both CNCs samples can be predicted by models assuming that the spin-spin relaxation occurs in the 
static-dephasing-regime (SDR).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S2. Compilation of in-vitro transverse relaxivities, r2, that allow comparison of the maghemite 
nanoclusters (CNCs) developed herein against other nanoarchitectures with potential in MR imaging. 
The materials were divided in two major categories depending on the nature of their magnetic state, 
namely, superparamagnetic (SPM) and ferrimagnetic (FiM). The regime, SDR or MAR, based on the 
outer sphere relaxation theory, in which they fall in is shown. The frequency, ν [= (γμ/2π) H], at which 
the relaxivity was measured, is also given. 
 
Magnetic 
State 
Type of 
nanoarchitecture 
Sample surface 
functionalisation  Regime r2 (mM
-1s-1) ν (MHz) 
SPM 
Individual 
NCs capped with polymer 3 MAR 11 60 
NCs capped with dendrons 4 MAR 349 64 
NCs capped with DHAA 5 MAR 121 64 
Endorema  SDR 99 64 
Encapsulated in 
matrices 
NCs encapsulated in 
Dextran 6 SDR 312 64 
NCs encapsulated in 
liposomes7 SDR 116 20 
Clusters 
Citrate-stabilized multi-core 
particles 8 SDR 365  9.25  
PVP-stabilized nanospheres 
9
 
SDR 94  64  
polystyrene-capped 
nanoclusters 10 SDR 435  128  
Dextran-coated 
nanoclusters 6 SDR 312  64  
PEG-stabilized nanoflowers 
11
 
SDR 238  64  
(Mal)mPEG-PLA 
copolymer-capped 
nanoclusters12 
SDR 465  60  
amine-stabilized 
nanoassemblies 13 SDR 315  85  
TREG-stabilized 
nanoclusters 14 SDR 295  400  
34 nm and 63 nm PAA 
capped nanoclusters 15, 16 SDR 
540 
630 64 
FiM 
Individual 
nanocubes encapsulated in 
PEG-phospholipids our 
system 17 
SDR 761 128 
Encapsulated in 
matrices 
liposome-encapsulated 
magnetic nanocluster 18.  SDR 1286  100 
Nanocrystal 
assemblies a 
PAA capped 50 nm 
nanoclustersa SDR 405 60 
PAA capped 86 nm 
nanoclustersa SDR 508 60 
a 
results of the present work 
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